SCHEMBL32669503

SCHEMBL32669503

CCN(Cc1cc(Cl)ccc1F)C(=O)/C(C#N)=C(\O)c1cc(OC)c(O)c([N+](=O)[O-])c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 8/20 0.60
COMT P21964 6/20 0.60
TTR P02766 1/20 0.41
MEN1 O00255 1/20 0.39
ABCC3 O15438 1/20 0.39
ABCC4 O15439 1/20 0.39
ABCB11 O95342 1/20 0.39
LMNA P02545 1/20 0.39
CYP2C9 P11712 1/20 0.39
KMT2A Q03164 1/20 0.39
GPR35 Q9HC97 1/20 0.39
ALDH1A1 P00352 2/20 0.38
EGFR P00533 2/20 0.38
G6PD P11413 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32669722 0.90 FTO (0.50) FTOCOMTTTRMEN1KMT2A
SCHEMBL32669965 0.89 FTO (0.49) FTOCOMTTTRMEN1KMT2A
SCHEMBL32669828 0.88 FTO (0.48) FTOCOMTTTRMEN1KMT2A
SCHEMBL32670114 0.88 FTO (0.48) FTOCOMTTTRMEN1KMT2A
SCHEMBL32669761 0.86 FTO (0.77) FTOCOMTTTRMEN1ABCC3
SCHEMBL32669939 0.85 FTO (0.49) FTOCOMTTTRMEN1KMT2A
SCHEMBL32669780 0.84 FTO (0.51) FTOCOMTTTREGFRG6PD
SCHEMBL32669502 0.84 FTO (0.51) FTOCOMTLMNAMAPT
SCHEMBL32669552 0.83 COMT (0.62) FTOCOMTTTRMEN1ABCC3
SCHEMBL32669738 0.83 FTO (0.52) FTOCOMTTTRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 FTO 1/4885COMT 52/4885TTR 655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.